GlaxoSmithKline plc (GSK) Rating Reiterated by Citigroup Inc.


's stock had its "buy" rating reaffirmed by Citigroup Inc. in a research report issued to clients and investors on Monday. They currently have a GBX 1,550 price target on the stock.



from Biotech News